VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹18 Cr | ₹19 Cr | ₹23 Cr | ₹25 Cr | ₹15 Cr |
What is the latest Total Non-Current Liabilities ratio of VIMTA LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹23 Cr |
| Mar2021 | ₹25 Cr |
| Mar2020 | ₹15 Cr |
How is Total Non-Current Liabilities of VIMTA LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹18 Cr | -2.45 | |
| Mar2023 | ₹19 Cr | -19.01 | |
| Mar2022 | ₹23 Cr | -6.78 | |
| Mar2021 | ₹25 Cr | 69.42 | |
| Mar2020 | ₹15 Cr | - | |
Compare Total Non-Current Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,289.8 Cr | -7.6% | -15.2% | 28.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -7.6% |
-15.2% |
28.4% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses